Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1886-1891

  Nilsson, Jan ^a   Calara, Federico ^a   Regnstrom, Jan ^a   Hultgardh Nilsson, Anna ^b   Ameli, Sean ^c   Cercek, Bojan ^c   Shah, Prediman K ^c,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IMMUNIZATION; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESTENOSIS; TREATMENT OUTCOME;

ANIMALS; ARTERIOSCLEROSIS; BALLOON DILATATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; IMMUNIZATION; LIPOPROTEINS, LDL; MALE; RABBITS; TUNICA INTIMA;

EID: 0031541903     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00366-5     Document Type: Article

References (36)

1. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest. 76:1985;125-131.
2. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131-138.
3. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis current knowledge and unanswered questions . Lab Invest. 64:1991;5-15.
4. Minick CR, Murphy GE. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet: II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet. Am J Pathol. 73:1973;265-292.
5. Tanaka H, Sukhova GK, Libby P. Interaction of the allogenic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb Vasc Biol. 14:1994;734-745.
6. Emeson EE, Shen M-L. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice-treated with cyclosporin A. Am J Pathol. 142:1993;1906-1915.
7. Roselaar SE, Schonfeld G, Daugherty A. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest. 96:1995;1389-1394.
8. Fyfe AI, Qiao JH, Lusis AJ. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest. 94:1994;2516-2520.
9. Hansson G, Holm J, Holm S, Fotev Z, Hedric JH, Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA. 88:1991;10530-10534.
10. Ferns G, Reidy M, Ross R. Vascular effects of cyclosporin A in vivo and in vitro. Am J Pathol. 137:1990;403-413.
11. Wiztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
12. Palinski W, Rosenfeld ME, Yla-Herttuala, et al. Low density lipoprotein undergoes modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
13. Stemme S, Faber B, Holm J, Wiklund O, Witztum J, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 92:1995;3893-3897.
14. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 12:1992;461-467.
15. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
16. Yla-Herttuala S, Palinsky W, Butler S, Picard S, Steinberg D, Witztum J. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 14:1994;32-40.
17. Palinski W, Miller E, Witztum J. Immunization of low density lipoprotein (LDL) receptor deficient rabbits with homologous malondialdehyde-modified LDL reduces atherosclerosis. Proc Natl Acad Sci USA. 92:1995;821-825.
18. Ameli S, Hultgardh-Nilsson A, Regnstrom J, et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 16:1996;1074-1079.
19. Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem. 65:1975;42-49.
20. Lowry O, Rosenbrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
21. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb Vasc Biol. 12:1992;789-799.
22. Ameli S, Hultgardh-Nilsson A, Cercek B, et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation. 90:1994;1935-1941.
23. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity . N Engl J Med. 320:1989;915-925.
25. Esterbauer H, Striegl G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun. 6:1989;67-75.
26. Steinbrecher U, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Rad Biol Med. 9:1990;155-168.
27. Steinberg D, Witztum JL. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
28. Gonen B, Fallon JJ, Baker SA. Immunogenicity of malonaldehyde-modified low density lipoprotein. Atherosclerosis. 65:1987;265-272.
29. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:1988;215-218.
30. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol. 15:1995;1569-1576.
31. Jovinge S, Ares M, Kallin B, Nilsson J. Human monocyte/macrophages release tumor necrosis factor alpha in response to oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 16:1996;1573-1579.
32. Stiko A, Regnstrom J, Shah PK, Cercek B, Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle DNA synthesis. Arterioscler Thromb Vasc Biol. 16:1996;194-200.
33. Ferns GAA, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Angard E. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci USA. 89:1992;11312-11316.
34. Freyschuss A, Stiko-Rahm A, Swedenborg J, et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 91:1993;1282-1288.
35. Hansson GK, Holm J. Interferon gamma inhibits arterial stenosis after injury. Circulation. 84:1991;1266-1272.
36. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferon gamma inhibits both proliferation and expression of alpha smooth muscle actin in arterial smooth muscle cells. J Exp Med. 170:1989;1595-1598.